FDA Inspection 1107101 — Synaptic Medical Limited
The FDA completed an inspection of Synaptic Medical Limited on Sep 12, 2019 in Beijing. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 12, 2019
- Fiscal Year
- 2019
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Beijing (China)